Therapy of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis.

@article{Seaworth2017TherapyOM,
  title={Therapy of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis.},
  author={Barbara Joyce Seaworth and David E. Griffith},
  journal={Microbiology spectrum},
  year={2017},
  volume={5 2}
}
The global epidemic of multidrug-resistant tuberculosis (MDR-TB) caused by Mycobacterium tuberculosis strains resistant to at least isoniazid and rifampin was recently reported as larger than previously estimated, with at least 580,000 new cases reported in 2015. Extensively drug-resistant tuberculosis (XDR-TB), MDR-TB with additional resistance to a second-line fluoroquinolone and injectable, continues to account for nearly 10% of MDR cases globally. Cases in India, China, and the Russian… CONTINUE READING